Pierrel
PRL | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005549644
- LEI:
- 8156002BC7CB6E3BD403
- Country:
- Italy
- Address:
- STRADA STATALE APPIA 7 BIS, 46/48, 81043 CAPUA
- Website:
- https://www.pierrelgroup.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pierrel is a global player in the pharmaceutical market, with over 70 years of experience in the field of oral care and listed at Euronext Milan of Borsa Italiana. Our legal and operational headquarters are in Capua, near Caserta and a few kilometers from Naples. The production facility received the first authorizations from the European Medicines Agency (EMA) in 1989 and from the Food and Drug Administration (FDA) in 2009 for the aseptic production of injectable drugs. Over the years, the core of our activity has been focused on the registration and marketing of dental anesthetics with Pierrel brand; including Orabloc, registered in the major international markets (including USA, Canada, Italy, Russia, Poland, Serbia, France, UK, Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia). Today, thanks to the FDA’s approval, we have a significant market share in the USA and we have numerous registrations going on all over the world.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2024-01-24 12:25 |
M&A Activity
Pierrel S.p.A.: OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA SULLE AZION…
|
Italian | 249.0 KB | |
2024-01-17 19:37 |
M&A Activity
Pierrel S.p.A.: OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA SULLE AZION…
|
Italian | 262.6 KB | |
2023-12-20 20:07 |
M&A Activity
Pierrel S.p.A.: Comunicato ai sensi dell’art. 41, co. 6 RE, emesso da PRL S.p.A…
|
Italian | 261.4 KB | |
2023-12-15 21:19 |
Regulatory News Service
Pierrel S.p.A.: Comunicato ai sensi dell’art. 36 del RE, emesso da PRL SpA
|
Italian | 230.9 KB | |
2023-12-14 20:16 |
Regulatory News Service
Pierrel S.p.A.: Comunicato ai sensi degli artt. 36 e 43 del Regolamento adottat…
|
Italian | 227.0 KB | |
2023-11-29 11:28 |
Prospectus
Pierrel S.p.A.: Bilancio d'esercizio al 31.12.2022
|
Italian | 4.9 MB | |
2023-11-28 21:23 |
Proxy Solicitation & Information Statement
Pierrel S.p.A.: Comunicato ai sensi dell’art. 36 del RE - emesso da PRL S.p.A. …
|
Italian | 242.8 KB | |
2023-11-24 23:43 |
M&A Activity
Pierrel S.p.A.: Comunicato ai sensi dell’art. 38, co. 2 RE,emesso da PRL S.p.A.…
|
Italian | 221.8 KB | |
2023-11-24 19:28 |
M&A Activity
Pierrel S.p.A.: IL CDA DI PIERREL APPROVA IL COMUNICATO DELL’EMITTENTE IN REL. …
|
Italian | 256.7 KB | |
2023-11-22 22:55 |
M&A Activity
Pierrel S.p.A.: PRL S.p.A. OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA …
|
Italian | 203.6 KB | |
2023-11-16 15:43 |
M&A Activity
Pierrel S.p.A.: Informazioni essenziali Addendum al patto parasociale – 16 nove…
|
Italian | 310.4 KB | |
2023-11-16 15:40 |
Regulatory News Service
Pierrel S.p.A.: Estratto Addendum al patto parasociale – 16 novembre 2023
|
Italian | 1.2 MB | |
2023-11-15 11:03 |
Regulatory News Service
Pierrel S.p.A.: Comunicato ai sensi dell’art. 38, co. 1, del Regolamento - AVVI…
|
Italian | 133.7 KB | |
2023-10-31 17:18 |
Regulatory News Service
Pierrel S.p.A.: Comunicato ai sensi dell’art. 38, co. 1,emesso da PRL S.p.A. e …
|
Italian | 141.2 KB | |
2023-10-24 11:11 |
Regulatory News Service
Pierrel S.p.A.: Comunicato ai sensi dell’art. 102, comma 3, del D.Lgs. 24 febbr…
|
Italian | 215.6 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP | |
ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
![]() |
Astellas Pharma Inc. | Japan | 4503 | |
![]() |
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
![]() |
Biofarm S.A. | Romania | BIO | |
![]() |
Biogened Spolka Akcyjna | Poland | BGD |